Oakridge International Limited delivered positive operating cash flow in Q3 2026, underpinned by steady customer receipts and ongoing product development, even as it navigates a potential legal claim from Teko International.
- Customer receipts near $1 million for the quarter
- Positive operating cash flow supported by government grants
- Progress on RTLS and NuCams platform development
- Active partner-led sales and project pipeline growth
- Legal exposure risk from Teko International claim continues
Positive Cash Flow and Revenue Momentum
Oakridge International (ASX:OAK) reported customer receipts of $988,000 for the quarter ended 31 March 2026, contributing to a year-to-date total of $2.192 million. This steady inflow supported positive operating cash flow of $369,000 for the period, a notable improvement given the company’s prior cash flow challenges. Government grants related to eligible development activities added $349,000, cushioning operational costs and underpinning the company’s improved cash position, which rose to $528,000 by quarter’s end.
The company’s financial trajectory builds on earlier momentum, following a 62% revenue surge and return to profitability reported in its half-year results, driven by healthcare technology sales and NuCaMS platform enhancements. This sustained performance reflects Oakridge’s focus on expanding its market footprint and product offerings within the healthcare sector 62% revenue surge and returns to profitability.
Advances in Product and Technology Development
Oakridge continued to invest heavily in its real-time location system (RTLS) and NuCams Enterprise platform developments during the quarter. Firmware improvements for RTLS hardware were completed, production hardware advanced, and enterprise reporting and integration capabilities neared key milestones. Software enhancements covered administration, authentication, reporting, and single sign-on features, with several workstreams approaching go-live readiness.
Product planning remains aligned with emerging nurse call standards, ensuring compliance and competitive positioning across new deployments. These technology developments are critical to maintaining Oakridge’s relevance in a competitive healthcare technology market, where integrated assistive and nurse call systems are increasingly in demand Advances in healthcare tech amid legal uncertainty.
Robust Partner Activity and Project Pipeline
Strategic partner relationships continue to drive national market coverage and revenue generation. The project pipeline includes a mix of partner-led and direct opportunities across Australia and select international markets, with several larger contracts pending purchase orders or final approvals. Project activity remained solid, with multiple installations progressing through programming, component delivery, and installation phases. Assisted living and accommodation-related programs also expanded, reflecting a broadening of Oakridge’s addressable market.
Management expects these qualified opportunities and ongoing channel activity to sustain revenue through the remainder of FY2026, though delivery timing and supply coordination remain key execution risks.
Legal Exposure from Teko International Claim
Despite operational progress, Oakridge faces a potential legal claim from Teko International Limited relating to alleged misrepresentations of unrecorded liabilities by the company’s former directors. The Board acknowledges some exposure and uncertainty over potential outcomes or defence costs. Negotiations and legal discussions are ongoing, with the company aiming to secure a favourable resolution for shareholders.
This legal cloud has been a recurring theme in Oakridge’s recent updates, adding a layer of risk to the company’s otherwise improving financial and operational performance Legal cloud over Oakridge International.
Operational Improvements and Market Engagement
Internally, Oakridge focused on systems and process enhancements to improve workflow, inventory visibility, finance integration, and reporting accuracy. These initiatives aim to support scalability and strengthen execution capabilities as the business grows. Marketing efforts also ramped up, with website development and digital campaigns enhancing brand visibility ahead of the ITAC Conference in Brisbane in early May 2026, offering further opportunities for customer and partner engagement.
Bottom Line?
Oakridge’s positive cash flow and technology progress are encouraging, but the unresolved legal claim by Teko International introduces a significant variable that could impact future financial outcomes.
Questions in the middle?
- How will the legal dispute with Teko International evolve and what financial impact could it have?
- Can Oakridge convert its substantial project pipeline into consistent revenue amid supply chain and delivery risks?
- Will the RTLS and NuCams platform developments meet market expectations and regulatory standards in time to drive growth?